Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 1, 2021
CSF-Derived CD4<sup>+</sup> T-Cell Diversity Is Reduced in Patients With Alzheimer Clinical Syndrome
Chaitanya Joshi, Karthigayini Sivaprakasam, Scott Christley, et al.
BMJ Open
|
February 10, 2026
Feasibility of the MAINTAIN intervention to support independence after a fall for people with dementia: a pilot cluster randomised controlled trial in participants' own homes
Leanne Greene, James Connors, Claire Hulme, et al.
BMJ Open
|
February 2, 2024
Maintaining independence in individuals with dementia at home after a fall: a protocol for the UK pilot cluster randomised controlled trial MAINTAIN
Leanne Greene, Robert Barber, Alison Bingham, et al.
Nature Reviews. Urology
|
January 16, 2026
Circulating tumour cells as a window into lethality in prostate cancer
Sophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton, et al.
The Lancet. Psychiatry
|
June 9, 2018
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial
Robert Howard, Elizabeth Cort, Rosie Bradley, et al.
Health Technology Assessment (Winchester, England)
|
December 4, 2018
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT
Robert Howard, Elizabeth Cort, Rosie Bradley, et al.
International Journal of Geriatric Psychiatry
|
October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)
Martin Knapp, Derek King, Renée Romeo, et al.
The Lancet. Neurology
|
October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
Robert Howard, Rupert McShane, James Lindesay, et al.
International Journal of Geriatric Psychiatry
|
September 18, 2010
Determining the minimum clinically important differences for outcomes in the DOMINO trial
Robert Howard, Patrick Phillips, Tony Johnson, et al.
The New England Journal of Medicine
|
March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Robert Howard, Rupert McShane, James Lindesay, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 1, 2021
CSF-Derived CD4<sup>+</sup> T-Cell Diversity Is Reduced in Patients With Alzheimer Clinical Syndrome
Chaitanya Joshi, Karthigayini Sivaprakasam, Scott Christley, et al.
BMJ Open
|
February 10, 2026
Feasibility of the MAINTAIN intervention to support independence after a fall for people with dementia: a pilot cluster randomised controlled trial in participants' own homes
Leanne Greene, James Connors, Claire Hulme, et al.
BMJ Open
|
February 2, 2024
Maintaining independence in individuals with dementia at home after a fall: a protocol for the UK pilot cluster randomised controlled trial MAINTAIN
Leanne Greene, Robert Barber, Alison Bingham, et al.
Nature Reviews. Urology
|
January 16, 2026
Circulating tumour cells as a window into lethality in prostate cancer
Sophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton, et al.
The Lancet. Psychiatry
|
June 9, 2018
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial
Robert Howard, Elizabeth Cort, Rosie Bradley, et al.
Health Technology Assessment (Winchester, England)
|
December 4, 2018
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT
Robert Howard, Elizabeth Cort, Rosie Bradley, et al.
International Journal of Geriatric Psychiatry
|
October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)
Martin Knapp, Derek King, Renée Romeo, et al.
The Lancet. Neurology
|
October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
Robert Howard, Rupert McShane, James Lindesay, et al.
International Journal of Geriatric Psychiatry
|
September 18, 2010
Determining the minimum clinically important differences for outcomes in the DOMINO trial
Robert Howard, Patrick Phillips, Tony Johnson, et al.
The New England Journal of Medicine
|
March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Robert Howard, Rupert McShane, James Lindesay, et al.
Page
of 11